Abstract:OPRM1 A118G is a common single nucleotide polymorphism (SNP) in the coding region of the human mu opioid receptor (MOPR) gene OPRM1. This SNP is associated with higher morphine doses required for postoperative analgesia as well as a variety of drug addiction phenotypes. A mouse model possessing the equivalent substitution (A112G) in the Oprm1 gene was generated to facilitate mechanistic studies. Mice homozygous for the G112 allele (G/G) displayed lower antinociception to morphine compared with those homozygous for A112 allele (A/A), similar to humans, suggesting that the mice are a good model to further characterize underlying factors contributing to phenotypes associated with this SNP. Here, we compared [3H]DAMGO binding to the MOPR in the brains of A/A and G/G mice using quantitative in vitro autoradiography. A/A mice exhibited higher [3H]DAMGO binding than G/G in the cingulate, motor, and insular cortices, nucleus accumbens core and shell, hypothalamus, thalamus, amygdala, periaqueductal gray, superficial gray of superior colliculus, and ventral tegmental area. No genotype differences were observed in somatosensory cortex, caudate putamen, and hippocampus. When males and females were examined separately, A/A mice showed higher [3H]DAMGO binding than G/G mice in more brain regions in males than in females. Radioligand binding using brain membranes also showed higher [3H]DAMGO binding in the cortex and thalamus in A/A mice than G/G mice but no genotype differences in the caudate putamen or hippocampus. Thus, the A112G SNP is associated with reduced MOPR expression in some, but not all, brain regions, and appears to have some sex differences. The elevated MOPR expression in periaqueductal gray and thalamus in A/A mice are consistent with their higher antinociceptive responses to morphine. The higher MOPR levels in nucleus accumbens and/or ventral tegmental area of A/A mice is consistent with the higher morphine-induced hyperactivity and locomotor sensitization observed in these mice. Thus, these results provide some insights into the observed decreased clinical opioid potency in humans with the A118G SNP.

Regulation of Mouse Kappa Opioid Receptor Gene Expression by Different 3 '-Untranslated Regions and the Effect of Retinoic Acid

Regulation of Mouse Kappa Opioid Receptor Gene Expression by Retinoids

Post-Transcriptional Regulation of Mouse κ-Opioid Receptor Expression

An Intronic Ikaros-binding Element Mediates Retinoic Acid Suppression of the Kappa Opioid Receptor Gene, Accompanied by Histone Deacetylation on the Promoters

Mouse Kappa-Opioid Receptor Mrna Differential Transport in Neurons

Influence Of Clonidine And Ketamine On M-Rna Expression In A Model Of Opioid-Induced Hyperalgesia In Mice

Kappa Opioid Receptors Negatively Regulate Real Time Spontaneous Dopamine Signals by Reducing Release and Increasing Uptake

Regulation of Delta Opioid Receptor Expression by Anti-Cd3-Epsilon, Pma, and Ionomycin in Murine Splenocytes and T Cells

Regulation of MOR‐1A, an Intron‐retention Splice Variant of the Mu Opioid Receptor (OPRM1) Gene, by Mir‐107

Dynorphin Activation of Kappa Opioid Receptor Reduces Neuronal Excitability in the Paraventricular Nucleus of Mouse Thalamus

Agonist-Promoted Phosphorylation and Internalization of the Kappa Opioid Receptor in Mouse Brains: Lack of Connection With Conditioned Place Aversion

Abstract P179: miR-214 Reduces Termination Efficiencies of Alternative Transcriptional Termination Sites

Morphine Regulates Expression Ofμ-Opioid Receptor MOR-1A, an Intron-Retention Carboxyl Terminal Splice Variant of Theμ-Opioid Receptor (OPRM1) Gene Via Mir-103/Mir-107

Differential Expressions of the Alternatively Spliced Variant Mrnas of the Μ Opioid Receptor Gene, OPRM1, in Brain Regions of Four Inbred Mouse Strains.

Exploring the Putative Mechanism of Allosteric Modulations by Mixed-Action Kappa/mu Opioid Receptor Bitopic Modulators.

Opioid-induced Regulation of Gene Expression in PC12 Cells Stably Transfected with Mu-Opioid Receptor.

Morphine Modulates the Expression of Mu-Opioid Receptor Exon 5-Associated Full-Length C-terminal Splice Variants by Upregulating Mir-378A-3p

Uncovering Kappa-Opioid Receptor Agonist-Induced PAK1/2 Phosphorylation by Quantitative Phosphoproteomics

Modulation of Ca2+/calmodulin-dependent Protein Kinase II Activity by Acute and Chronic Morphine Administration in Rat Hippocampus: Differential Regulation of Alpha and Beta Isoforms.

μ-Opioid receptor transcriptional variants in the murine forebrain and spinal cord

Reduced Expression of the Mu Opioid Receptor in Some, but Not All, Brain Regions in Mice with Oprm1 A112g